Search Results 231-240 of 17179 for Glucagon

  1. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Atropine sulfate (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Glucagon; Glycopyrrolate; Glycopyrronium Tosylate; Hydrocodone; Hydromorphone; Hydroxychloroquine; LetibotulinumtoxinA-wlbg; Macimorelin; Meperidine ...

  3. Glucarpidase (intravenous route) - Side effects & uses - Mayo Clinic

    Glucarpidase injection is used to treat too much methotrexate concentration in the blood in patients with severe kidney disease. This medicine is to be given ...

  4. Predictive Role of Non-Invasive Glucose Assessment During Pregnancy - Mayo Clinic

    This study aims to determine the value of regular, non-invasive [glucose] LabClasp monitoring during pregnancy. Participation eligibility. Participant ...

  5. Trihexyphenidyl (oral route) - Side effects & dosage - Mayo Clinic

    Fentanyl; Glucagon; Glycopyrrolate; Glycopyrronium Tosylate; Hydrocodone; Hydromorphone; LetibotulinumtoxinA-wlbg; Meperidine; Methacholine; Methadone ...

  6. Thiothixene (oral route) - Side effects & dosage - Mayo Clinic

    Glucagon; Glycopyrrolate; Glycopyrronium Tosylate; Hydrocodone; Hydromorphone; Hydroxychloroquine; Insulin Aspart, Recombinant; LetibotulinumtoxinA-wlbg ...

  7. Publications - Michelle A. Anderson, M.D. - Mayo Clinic

    PANCREATIC SAFETY IN STUDIES OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ALBIGLUTIDE. Endocr Pract. 2019 Jul; 25 (7):698-716 Epub 2019 Mar 13. View ...

  8. Glycopyrrolate (intramuscular route, intravenous route) - Mayo Clinic

    Glucagon; Glycopyrronium Tosylate; Homatropine. Show More. Other Interactions. Certain medicines should not be used at or around the time of eating food or ...

  9. Macroglobulinemia Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the safety and effectiveness of the BCL2 inhibitor BGB-11417 in participants with relapsed/refractory Waldenström's ...

  10. Publications - Bryan Springer, M.D. - Mayo Clinic

    ... Glucagon-Like Peptide-1 Receptor Agonists and Bariatric Surgery. Arthroplast Today. 2026 Apr; 38:101988 Epub 2026 Mar 10. View PubMed; Morrell AT, Zaniletti I ...